Development of data science course and summer bootcamp for ADRD researchers
为 ADRD 研究人员开发数据科学课程和夏季训练营
基本信息
- 批准号:10405365
- 负责人:
- 金额:$ 8.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-15 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Abstract
Given the rising prominence of data science in biomedical and Alzheimer’s research, fueled by
recent developments in artificial intelligence (AI), especially deep learning, and high-
performance computer hardware; a need has emerged to broadly train the predoctoral students
in data science, in both its fundamental principles, and its applications to Alzheimer’s disease
and related dementia (ADRD).
To this end, we will develop a spring 2022 course with seven modular units in the following
areas: 1. Fundamentals and overview (Lai and C. Wang); 2. Deep learning (G. Wang and Lai);
3. Bioinformatics (Bystroff and Fraser); 4. Medical imaging and ADRD (G. Wang and Yan); 5.
Systems engineering (Hahn); 6. Multi-omics (Hurley and Fraser); 7. AI and drug discovery (C.
Wang, Dordick and Fraser).
During the summer of 2022, we will develop a data science bootcamp to provide the students
with hands-on experience in data science, featuring a week-long intensive training in R, followed
by a coached project to analyze an ADRD dataset, e.g., from AD knowledge portal
(https://adknowledgeportal.synapse.org). The course will culminate in a mini-conference where
the students present their research results to a panel of domain experts.
Both the new course and summer camp will be developed and taught in person and will also be
recorded and made available via an online platform to the NIA T32 trainees and graduate
students from the Departments of Architecture, Biological Sciences, Biomedical Engineering,
Chemical Engineering and Chemistry at Rensselaer. All the training materials will be regularly
updated and made freely available to the scientific community through Rensselaer’s web
portal and as new training modules through the institution’s online training
platform Percipio. Using online quizzes, surveys and in-person interviews, the newly developed
course and bootcamp will be evaluated for efficacy, effectiveness and sustainability.
抽象的
鉴于生物医学和阿尔茨海默氏症研究中数据科学的突出性不断提高,这在
人工智能(AI)的最新发展,尤其是深度学习和高知
性能计算机硬件;已经出现了广泛训练前学生的需求
在数据科学方面,其基本原理及其对阿尔茨海默氏病的应用
和相关痴呆(ADRD)。
为此,我们将开发一门2022春季课程,其中有七个模块化单元
区域:1。基本原理和概述(Lai和C. Wang); 2。深度学习(G. Wang和Lai);
3。生物信息学(Bystroff和Fraser); 4。医学成像和Adrd(G. Wang and Yan); 5。
系统工程(Hahn); 6。多派(Hurley and Fraser); 7. AI和药物发现(C.
Wang,Dordick和Fraser)。
在2022年夏季,我们将开发一个数据科学训练营来为学生提供
具有数据科学的动手经验,在R中进行了为期一周的强化培训,随后进行
由一个指导的项目分析ADRD数据集,例如从广告知识门户
(https://adknowledgeportal.synapse.org)。该课程将在小型会议中达到高潮
学生将他们的研究结果介绍给域专家小组。
新课程和夏令营都将亲自发展和教授,也将是
通过在线平台录制并提供NIA T32培训和毕业生
来自建筑,生物科学,生物医学工程部门的学生,
伦斯勒的化学工程和化学。所有培训材料将定期
通过Rensselaer的网络更新并免费提供给科学界
门户和作为该机构在线培训的新培训模块
平台Percipio。使用在线测验,调查和面对面访谈,新开发
课程和训练营将进行评估,以确保有效性,有效性和可持续性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chunyu Wang其他文献
Chunyu Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chunyu Wang', 18)}}的其他基金
Predoctoral Training Program for Alzheimer’s Disease at the Interface of Data Science, Engineering and Biology
数据科学、工程和生物学交叉领域的阿尔茨海默病博士前培训项目
- 批准号:
10628106 - 财政年份:2023
- 资助金额:
$ 8.07万 - 项目类别:
The Alzheimer's Disease Clinical and Translational Research (ADCTR) Training Program
阿尔茨海默病临床和转化研究 (ADCTR) 培训计划
- 批准号:
10221565 - 财政年份:2017
- 资助金额:
$ 8.07万 - 项目类别:
The Alzheimer's Disease Clinical and Translational Research (ADCTR) Training Program
阿尔茨海默病临床和转化研究 (ADCTR) 培训计划
- 批准号:
9977904 - 财政年份:2017
- 资助金额:
$ 8.07万 - 项目类别:
Testing novel hypotheses in Mtu RecA intein splicing
测试 Mtu RecA 内含肽剪接的新假设
- 批准号:
8000230 - 财政年份:2010
- 资助金额:
$ 8.07万 - 项目类别:
Testing novel hypotheses in Mtu RecA intein splicing
测试 Mtu RecA 内含肽剪接的新假设
- 批准号:
7911738 - 财政年份:2007
- 资助金额:
$ 8.07万 - 项目类别:
Testing novel hypotheses in Mtu RecA intein splicing
测试 Mtu RecA 内含肽剪接的新假设
- 批准号:
7483631 - 财政年份:2007
- 资助金额:
$ 8.07万 - 项目类别:
Testing novel hypotheses in Mtu RecA intein splicing
测试 Mtu RecA 内含肽剪接的新假设
- 批准号:
7299036 - 财政年份:2007
- 资助金额:
$ 8.07万 - 项目类别:
Testing novel hypotheses in Mtu RecA intein splicing
测试 Mtu RecA 内含肽剪接的新假设
- 批准号:
7680970 - 财政年份:2007
- 资助金额:
$ 8.07万 - 项目类别:
Testing novel hypotheses in Mtu RecA intein splicing
测试 Mtu RecA 内含肽剪接的新假设
- 批准号:
7681489 - 财政年份:2007
- 资助金额:
$ 8.07万 - 项目类别:
Testing novel hypotheses in Mtu RecA intein splicing
测试 Mtu RecA 内含肽剪接的新假设
- 批准号:
8136454 - 财政年份:2007
- 资助金额:
$ 8.07万 - 项目类别:
相似海外基金
Cognitive Health and Modifiable Factors of Daily Sleep and Activities Among Dementia Family Caregivers
痴呆症家庭护理人员的认知健康状况以及日常睡眠和活动的可改变因素
- 批准号:
10643624 - 财政年份:2023
- 资助金额:
$ 8.07万 - 项目类别:
ACTS (AD Clinical Trial Simulation): Developing Advanced Informatics Approaches for an Alzheimer's Disease Clinical Trial Simulation System
ACTS(AD 临床试验模拟):为阿尔茨海默病临床试验模拟系统开发先进的信息学方法
- 批准号:
10753675 - 财政年份:2023
- 资助金额:
$ 8.07万 - 项目类别:
Brain Digital Slide Archive: An Open Source Platform for data sharing and analysis of digital neuropathology
Brain Digital Slide Archive:数字神经病理学数据共享和分析的开源平台
- 批准号:
10735564 - 财政年份:2023
- 资助金额:
$ 8.07万 - 项目类别:
Integrative Data Science Approach to Advance Care Coordination of ADRD by Primary Care Providers
综合数据科学方法促进初级保健提供者对 ADRD 的护理协调
- 批准号:
10722568 - 财政年份:2023
- 资助金额:
$ 8.07万 - 项目类别:
Preparing for Blood-Based Alzheimer’s Disease Biomarker Testing in Diverse Populations: Development of a Decision-Support Tool for Primary Care
为不同人群进行基于血液的阿尔茨海默病生物标志物测试做好准备:开发初级保健决策支持工具
- 批准号:
10722716 - 财政年份:2023
- 资助金额:
$ 8.07万 - 项目类别: